杏林製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4569/E00985 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2015/07/24 | 日証協 | 379,936株 | -14.63% | 74,400株 | -52.03% | 659,995株 | -6.04% | 100,899株 | -9.59% |
2015/07/17 | 日証協 | 445,036株 | +2.32% | 155,104株 | +78.49% | 702,395株 | +6.23% | 111,599株 | -15.84% |
2015/07/10 | 日証協 | 434,955株 | +14.51% | 86,900株 | +769% | 661,195株 | +7.15% | 132,600株 | +99.4% |
2015/07/03 | 日証協 | 379,855株 | -0.56% | 10,000株 | +875.61% | 617,095株 | +1.28% | 66,499株 | -73.06% |
2015/06/26 | 日証協 | 381,985株 | -0.64% | 1,025株 | -98% | 609,295株 | +37.16% | 246,799株 | -8.03% |
2015/06/19 | 日証協 | 384,463株 | +35.77% | 51,231株 | +9999.99% | 444,224株 | +81.22% | 268,339株 | +1276.1% |
2015/06/12 | 日証協 | 283,176株 | +0.04% | 425株 | -79.76% | 245,136株 | -2.51% | 19,500株 | -61.88% |
2015/06/05 | 日証協 | 283,051株 | -1.3% | 2,100株 | -96.14% | 251,436株 | -9.53% | 51,153株 | -10.95% |
2015/05/29 | 日証協 | 286,787株 | 0% | 54,342株 | 0% | 277,936株 | 0% | 57,442株 | 0% |
2015/05/15 | 日証協 | 268,587株 | -6.26% | 54,500株 | +4441.67% | 344,124株 | -5.69% | 16,203株 | -72.84% |
2015/05/08 | 日証協 | 286,523株 | -0.1% | 1,200株 | -33.33% | 364,873株 | -2.9% | 59,651株 | +455.31% |
2015/05/01 | 日証協 | 286,823株 | -0.55% | 1,800株 | -71.43% | 375,773株 | -0.52% | 10,742株 | -82.53% |
2015/04/24 | 日証協 | 288,423株 | -5.73% | 6,300株 | -83.31% | 377,731株 | -4.26% | 61,500株 | -5.38% |
2015/04/17 | 日証協 | 305,940株 | +0.54% | 37,736株 | -73.39% | 394,548株 | -5.1% | 65,000株 | +144.36% |
2015/04/10 | 日証協 | 304,304株 | -8.98% | 141,825株 | +8.64% | 415,748株 | -13.88% | 26,600株 | -84.47% |
2015/04/03 | 日証協 | 334,340株 | +24.42% | 130,542株 | -47.26% | 482,749株 | +24.62% | 171,307株 | -36.74% |
2015/03/20 | 日証協 | 311,837株 | +16.34% | 98,442株 | +1.59% | 383,724株 | -4.91% | 97,600株 | +58.44% |
2015/03/13 | 日証協 | 268,037株 | +24.12% | 96,900株 | +9999.99% | 403,524株 | +15.71% | 61,600株 | -34.47% |
2015/03/06 | 日証協 | 215,947株 | -0.64% | 200株 | -99.43% | 348,734株 | -0.68% | 94,000株 | -27.73% |
※株式分割は考慮していませんのでご注意ください。
Page Top